1-162753056-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006182.4(DDR2):c.83-39C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.995 in 1,552,036 control chromosomes in the GnomAD database, including 769,298 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.98 ( 72691 hom., cov: 31)
Exomes 𝑓: 1.0 ( 696607 hom. )
Consequence
DDR2
NM_006182.4 intron
NM_006182.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0130
Publications
5 publications found
Genes affected
DDR2 (HGNC:2731): (discoidin domain receptor tyrosine kinase 2) This gene encodes a member of the discoidin domain receptor subclass of the receptor tyrosine kinase (RTKs) protein family. RTKs play a key role in the communication of cells with their microenvironment. The encoded protein is a collagen-induced receptor that activates signal transduction pathways involved in cell adhesion, proliferation, and extracellular matrix remodeling. This protein is expressed in numerous cell types and may alos be involved in wound repair and regulate tumor growth and invasiveness. Mutations in this gene are the cause of short limb-hand type spondylometaepiphyseal dysplasia. [provided by RefSeq, Aug 2017]
DDR2 Gene-Disease associations (from GenCC):
- spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- warburg-cinotti syndromeInheritance: Unknown, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Illumina, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-162753056-C-G is Benign according to our data. Variant chr1-162753056-C-G is described in ClinVar as Benign. ClinVar VariationId is 259936.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DDR2 | NM_006182.4 | c.83-39C>G | intron_variant | Intron 3 of 17 | ENST00000367921.8 | NP_006173.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DDR2 | ENST00000367921.8 | c.83-39C>G | intron_variant | Intron 3 of 17 | 1 | NM_006182.4 | ENSP00000356898.3 |
Frequencies
GnomAD3 genomes AF: 0.976 AC: 148567AN: 152150Hom.: 72646 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
148567
AN:
152150
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.994 AC: 249039AN: 250582 AF XY: 0.995 show subpopulations
GnomAD2 exomes
AF:
AC:
249039
AN:
250582
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.998 AC: 1396365AN: 1399768Hom.: 696607 Cov.: 20 AF XY: 0.998 AC XY: 698573AN XY: 700050 show subpopulations
GnomAD4 exome
AF:
AC:
1396365
AN:
1399768
Hom.:
Cov.:
20
AF XY:
AC XY:
698573
AN XY:
700050
show subpopulations
African (AFR)
AF:
AC:
29410
AN:
32164
American (AMR)
AF:
AC:
44269
AN:
44462
Ashkenazi Jewish (ASJ)
AF:
AC:
25590
AN:
25590
East Asian (EAS)
AF:
AC:
39262
AN:
39264
South Asian (SAS)
AF:
AC:
84737
AN:
84758
European-Finnish (FIN)
AF:
AC:
52840
AN:
52840
Middle Eastern (MID)
AF:
AC:
5291
AN:
5310
European-Non Finnish (NFE)
AF:
AC:
1057185
AN:
1057300
Other (OTH)
AF:
AC:
57781
AN:
58080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
180
360
539
719
899
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20278
40556
60834
81112
101390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.976 AC: 148670AN: 152268Hom.: 72691 Cov.: 31 AF XY: 0.977 AC XY: 72725AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
148670
AN:
152268
Hom.:
Cov.:
31
AF XY:
AC XY:
72725
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
38112
AN:
41526
American (AMR)
AF:
AC:
15169
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
3472
AN:
3472
East Asian (EAS)
AF:
AC:
5168
AN:
5168
South Asian (SAS)
AF:
AC:
4821
AN:
4822
European-Finnish (FIN)
AF:
AC:
10628
AN:
10628
Middle Eastern (MID)
AF:
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
AC:
68016
AN:
68036
Other (OTH)
AF:
AC:
2079
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
160
320
481
641
801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3471
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Apr 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Warburg-cinotti syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.